Home › Roche Diagnostics GmbH › Tina-quant Cystatin C Gen.2
Tina-quant Cystatin C Gen.2
Roche Diagnostics GmbH · Model 08105596190 · UDI-DI 07613336133644
NDY
Prescription
1
510(k) clearances
21
Adverse events
4
Recalls
24
Facilities
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2024-06-07 | Randox Laboratories Ltd. | Cystatin C Reagent marketed without a 510 (k) |
| 2024-02-14 | Randox Laboratories Ltd. | Cystatin C Calibrator Series CVS 2699, is running with a negative bias compared to other methods |
| 2020-09-02 | Gentian AS | The firm has identified lots of calibrators that have shown to measure incorrect high values over time compared to the assigned values when released for distribution. This could re |
| 2018-03-05 | Tosoh Bioscience Inc | Asfotase Alfa (Strensiq) interferes with certain Tosoh assays which potentially causes falsely increased or falsely decreased immunoassay test results, depending upon the assay. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.